Platelet-derived microparticles provoke chronic lymphocytic leukemia malignancy through metabolic reprogramming

Abstract

Altogether, these findings depict a new platelet-mediated pathway of cancer pathogenesis. We also highlight the impact of PMPs in CLL metabolic reprogramming and disease progression.